Article Versions Notes

Caviglia GP, Rosso C, Stalla F, Rizzo M, Massano A, Abate ML, Olivero A, Armandi A, Vanni E, Younes R, et al. On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine. 2020; 9(3):800. https://doi.org/10.3390/jcm9030800

Caviglia, Gian Paolo, Chiara Rosso, Francesco Stalla, Martina Rizzo, Alessandro Massano, Maria Lorena Abate, Antonella Olivero, Angelo Armandi, Ester Vanni, Ramy Younes, and et al. 2020. "On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases" Journal of Clinical Medicine 9, no. 3: 800. https://doi.org/10.3390/jcm9030800

Caviglia, G. P., Rosso, C., Stalla, F., Rizzo, M., Massano, A., Abate, M. L., Olivero, A., Armandi, A., Vanni, E., Younes, R., Fagoonee, S., Pellicano, R., Astegiano, M., Saracco, G. M., Bugianesi, E., & Ribaldone, D. G. (2020). On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine, 9(3), 800. https://doi.org/10.3390/jcm9030800